Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.50NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.2.14NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
unclassifiableNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KS.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HH.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XCENChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HN.4.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GU.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.4.6.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.18NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.12.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LZ.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.3.1.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KW.1.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KU.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.4.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.2.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LP.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.3.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.4.6.5NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BA.2.18NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BA.2.12.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
LZ.1.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
KP.3.1.5NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
KW.1.1.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
KU.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
JN.1.4.6NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
KP.2.5NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
LP.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
KP.3.1.3NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
GQ.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
JA.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
EG.5.1.10NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
FL.2.7.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
EG.9.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
XBB.2.3.22NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
JV.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BA.2.3.4NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
CH.1.1.7NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
XBB.1.27NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BQ.1.10.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-21956.6US
BQ.1.1.36NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-21956.6US
EF.1.1.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-21956.6US
BQ.1.32NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-21956.6US
EK.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
XBB.2.6.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
DV.5NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
FL.23.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used